cytarabine and xav939
cytarabine has been researched along with xav939 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cai, Z; Gong, Y; Kim, SB; Lee, JS; Mallampati, S; Sun, B; Sun, X; Yang, Y; Zhang, J | 1 |
Other Studies
1 other study(ies) available for cytarabine and xav939
| Article | Year |
|---|---|
Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target.
Topics: Animals; Apoptosis; beta Catenin; Cell Cycle; Cytarabine; Gene Expression Regulation, Leukemic; Heterocyclic Compounds, 3-Ring; Humans; Mesenchymal Stem Cells; Mice; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Wnt Signaling Pathway | 2013 |